BiotechTube

Etonogestrel contraceptive implant

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Contraceptive Usage

Conditions

Contraceptive Usage

Trial Timeline

Jan 1, 2010 → Jan 1, 2013

NCT ID
NCT03585504

About Etonogestrel contraceptive implant

Etonogestrel contraceptive implant is a phase 3 stage product being developed by Bayer for Contraceptive Usage. The current trial status is completed. This product is registered under clinical trial identifier NCT03585504. Target conditions include Contraceptive Usage.

What happened to similar drugs?

0 of 4 similar drugs in Contraceptive Usage were approved

Approved (0) Terminated (0) Active (4)
🔄Levonorgestrel 90 mg and Ethinyl Estradiol 20 mgPfizerPhase 3
🔄EE20/DRSP (YAZ, BAY86-5300) + Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)BayerPhase 3
🔄EV/DNG (Qlaira, BAY86-5027) + Encapsulated Microgynon + PlaceboBayerPhase 3
🔄Valette (Dienogest/EE30, BAY86-5038) + Valette (Dienogest/EE30, BAY86-5038)BayerPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03585504Phase 3Completed

Competing Products

13 competing products in Contraceptive Usage

See all competitors
ProductCompanyStageHype Score
AZD1981 + Neovletta 21/28 + Placebo AZD1981AstraZenecaPhase 1
29
fostamatinib + Microgynon® 30 (Oral contraceptive) + PlaceboAstraZenecaPhase 1
29
Leios/AlessePfizerPre-clinical
26
Levonorgestrel 90 mg and Ethinyl Estradiol 20 mgPfizerPhase 3
40
EE20/DRSP (YAZ, BAY86-5300) + Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)BayerPhase 3
37
EV/DNG (Qlaira, BAY86-5027) + Encapsulated Microgynon + PlaceboBayerPhase 3
37
SH T04769G + Ethinyl estradiol / dienogest (SH D00659 AF)BayerPhase 2
32
E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) + E2/DRSP (BAY 86-4891) dose 2 (80458739) + E2/DRSP (BAY 86-4891) dose 3 (80458755) + E2/DRSP (BAY 86-4891) dose 4 (80458720) + E2/DRSP (BAY 86-4891) dose 5 (80458712) + DRSP (ZK 30595) dose 1 (SH T04984F) + DRSP (ZK 30595) dose 2 (80458690) + PlaceboBayerPhase 2
32
Valette (Dienogest/EE30, BAY86-5038) + Valette (Dienogest/EE30, BAY86-5038)BayerPhase 3
37
EV/DNG (Qlaira, BAY86-5027) + Progestin Only PillsBayerPre-clinical
23
Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040)BayerPre-clinical
23
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) + Yasminelle (SH T 00186 D)BayerPhase 2
32
Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2BayerPhase 1
26